Watershed Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Series 2

  • Latest Deal Amount
  • $2M

  • Investors
  • 10

Watershed Therapeutics General Information

Description

Developer of a novel targeted drug-delivery technology designed to provide treatment for bladder diseases. The company's technology focuses on utilizing treatment and prophylaxis, acute and chronic therapy, delivery of larger drug payload, and other related medical services, enabling clinicians or healthcare professionals to help their patients in improving their quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 9841 North East 15th Street
  • Bellevue, WA 98004
  • United States
+1 (314)
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Pharmaceuticals
Corporate Office
  • 9841 North East 15th Street
  • Bellevue, WA 98004
  • United States
+1 (314)

Watershed Therapeutics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Watershed Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 07-Apr-2023 $2M Completed Clinical Trials - Phase 1
2. Accelerator/Incubator 01-Sep-2022 Completed Pre-Clinical Trials
1. Seed Round 15-Aug-2022 $2.48M $2.48M Completed Pre-Clinical Trials
To view Watershed Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Watershed Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a novel targeted drug-delivery technology designed to provide treatment for bladder diseases. The company's
Drug Discovery
Bellevue, WA
5 As of 2024

Princeton, NJ
 

Woburn, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Watershed Therapeutics Competitors (2)

One of Watershed Therapeutics’s 2 competitors is Urogen Pharma, a Formerly VC-backed company based in Princeton, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Urogen Pharma Formerly VC-backed Princeton, NJ
Taris Biomedical Corporation Woburn, MA
You’re viewing 2 of 2 competitors. Get the full list »

Watershed Therapeutics Patents

Watershed Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023255693-A1 Formulation for treating urinary system disorders Pending 19-Apr-2022
CA-3214668-A1 Formulation and method for treatment of urinary system disorders Pending 07-Apr-2021
EP-4319724-A1 Formulation and method for treatment of urinary system disorders Pending 07-Apr-2021
AU-2021439740-A1 Formulation and method for treatment of urinary system disorders Pending 07-Apr-2021
US-20240189237-A1 Formulation and method for treatment of urinary system disorders Pending 07-Apr-2021 A61K31/635
To view Watershed Therapeutics’s complete patent history, request access »

Watershed Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Watershed Therapeutics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Charleston Angel Partners Angel Group Minority
Serial Stage Venture Partners Venture Capital Minority
Sierra Angels Angel Group Minority
WTIA Startup Program Accelerator/Incubator
4i Ventures Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Watershed Therapeutics FAQs

  • When was Watershed Therapeutics founded?

    Watershed Therapeutics was founded in 2019.

  • Where is Watershed Therapeutics headquartered?

    Watershed Therapeutics is headquartered in Bellevue, WA.

  • What is the size of Watershed Therapeutics?

    Watershed Therapeutics has 5 total employees.

  • What industry is Watershed Therapeutics in?

    Watershed Therapeutics’s primary industry is Drug Discovery.

  • Is Watershed Therapeutics a private or public company?

    Watershed Therapeutics is a Private company.

  • What is the current valuation of Watershed Therapeutics?

    The current valuation of Watershed Therapeutics is .

  • What is Watershed Therapeutics’s current revenue?

    The current revenue for Watershed Therapeutics is .

  • How much funding has Watershed Therapeutics raised over time?

    Watershed Therapeutics has raised $4.48M.

  • Who are Watershed Therapeutics’s investors?

    Charleston Angel Partners, Serial Stage Venture Partners, Sierra Angels, WTIA Startup Program, and 4i Ventures are 5 of 10 investors who have invested in Watershed Therapeutics.

  • Who are Watershed Therapeutics’s competitors?

    Urogen Pharma and Taris Biomedical are competitors of Watershed Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »